Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX - US4576511079 - Common Stock

16.64 USD
-0.07 (-0.42%)
Last: 8/27/2025, 8:04:01 PM
16.64 USD
0 (0%)
After Hours: 8/27/2025, 8:04:01 PM
Fundamental Rating

7

Overall INVX gets a fundamental rating of 7 out of 10. We evaluated INVX against 61 industry peers in the Energy Equipment & Services industry. INVX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INVX is not overvalued while it is showing excellent growth. This is an interesting combination. This makes INVX very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

INVX had positive earnings in the past year.
INVX had a positive operating cash flow in the past year.
In multiple years INVX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: INVX reported negative operating cash flow in multiple years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

INVX has a better Return On Assets (11.77%) than 95.08% of its industry peers.
The Return On Equity of INVX (14.51%) is better than 77.05% of its industry peers.
INVX's Return On Invested Capital of 7.20% is fine compared to the rest of the industry. INVX outperforms 62.30% of its industry peers.
Industry RankSector Rank
ROA 11.77%
ROE 14.51%
ROIC 7.2%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

INVX has a Profit Margin of 16.66%. This is amongst the best in the industry. INVX outperforms 91.80% of its industry peers.
In the last couple of years the Profit Margin of INVX has grown nicely.
INVX has a better Operating Margin (11.37%) than 63.93% of its industry peers.
INVX's Operating Margin has improved in the last couple of years.
INVX's Gross Margin of 32.96% is fine compared to the rest of the industry. INVX outperforms 65.57% of its industry peers.
In the last couple of years the Gross Margin of INVX has grown nicely.
Industry RankSector Rank
OM 11.37%
PM (TTM) 16.66%
GM 32.96%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

INVX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, INVX has more shares outstanding
The number of shares outstanding for INVX has been increased compared to 5 years ago.
The debt/assets ratio for INVX is higher compared to a year ago.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

INVX has an Altman-Z score of 4.73. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
INVX has a better Altman-Z score (4.73) than 93.44% of its industry peers.
INVX has a debt to FCF ratio of 0.23. This is a very positive value and a sign of high solvency as it would only need 0.23 years to pay back of all of its debts.
INVX has a better Debt to FCF ratio (0.23) than 93.44% of its industry peers.
INVX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
INVX has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. INVX outperforms 86.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.23
Altman-Z 4.73
ROIC/WACC0.79
WACC9.06%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

INVX has a Current Ratio of 4.60. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
INVX has a Current ratio of 4.60. This is amongst the best in the industry. INVX outperforms 91.80% of its industry peers.
INVX has a Quick Ratio of 2.69. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of INVX (2.69) is better than 88.52% of its industry peers.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 2.69
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

9

3. Growth

3.1 Past

INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 204.76%, which is quite impressive.
INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 123.23% yearly.
Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 41.65%.
Measured over the past years, INVX shows a quite strong growth in Revenue. The Revenue has been growing by 9.76% on average per year.
EPS 1Y (TTM)204.76%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%130%
Revenue 1Y (TTM)41.65%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%86.33%

3.2 Future

The Earnings Per Share is expected to grow by 148.21% on average over the next years. This is a very strong growth
INVX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.16% yearly.
EPS Next Y493%
EPS Next 2Y148.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year93.68%
Revenue Next 2Y40.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.21, which means the current valuation is very expensive for INVX.
Compared to the rest of the industry, the Price/Earnings ratio of INVX is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.14, INVX is valued at the same level.
INVX is valuated reasonably with a Price/Forward Earnings ratio of 11.76.
75.41% of the companies in the same industry are more expensive than INVX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of INVX to the average of the S&P500 Index (22.80), we can say INVX is valued slightly cheaper.
Industry RankSector Rank
PE 25.21
Fwd PE 11.76
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

INVX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. INVX is more expensive than 68.85% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, INVX is valued cheaply inside the industry as 86.89% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.35
EV/EBITDA 7.51
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INVX may justify a higher PE ratio.
INVX's earnings are expected to grow with 148.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.05
PEG (5Y)0.2
EPS Next 2Y148.21%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INVX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVEX INTERNATIONAL INC

NYSE:INVX (8/27/2025, 8:04:01 PM)

After market: 16.64 0 (0%)

16.64

-0.07 (-0.42%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)N/A N/A
Inst Owners47.97%
Inst Owner Change4.52%
Ins Owners1.52%
Ins Owner Change6.6%
Market Cap1.14B
Analysts77.78
Price Target18.7 (12.38%)
Short Float %N/A
Short Ratio7.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP51.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.38%
Min EPS beat(2)-24.08%
Max EPS beat(2)-22.68%
EPS beat(4)1
Avg EPS beat(4)-40.73%
Min EPS beat(4)-165.36%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-164.95%
EPS beat(12)3
Avg EPS beat(12)-83.38%
EPS beat(16)3
Avg EPS beat(16)-90.25%
Revenue beat(2)1
Avg Revenue beat(2)1.36%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)7.14%
Revenue beat(4)3
Avg Revenue beat(4)5.8%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.25%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.85%
PT rev (3m)14.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.69%
EPS NY rev (1m)12.06%
EPS NY rev (3m)12.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.47%
Revenue NY rev (1m)2.28%
Revenue NY rev (3m)-8.41%
Valuation
Industry RankSector Rank
PE 25.21
Fwd PE 11.76
P/S 1.32
P/FCF 6.35
P/OCF 5.81
P/B 1.15
P/tB 1.47
EV/EBITDA 7.51
EPS(TTM)0.66
EY3.97%
EPS(NY)1.41
Fwd EY8.5%
FCF(TTM)2.62
FCFY15.74%
OCF(TTM)2.87
OCFY17.23%
SpS12.61
BVpS14.47
TBVpS11.29
PEG (NY)0.05
PEG (5Y)0.2
Profitability
Industry RankSector Rank
ROA 11.77%
ROE 14.51%
ROCE 9.12%
ROIC 7.2%
ROICexc 7.69%
ROICexgc 9.81%
OM 11.37%
PM (TTM) 16.66%
GM 32.96%
FCFM 20.77%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.23
Debt/EBITDA 0.23
Cap/Depr 33.62%
Cap/Sales 1.96%
Interest Coverage 250
Cash Conversion 132.1%
Profit Quality 124.67%
Current Ratio 4.6
Quick Ratio 2.69
Altman-Z 4.73
F-Score6
WACC9.06%
ROIC/WACC0.79
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)204.76%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%130%
EPS Next Y493%
EPS Next 2Y148.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)41.65%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%86.33%
Revenue Next Year93.68%
Revenue Next 2Y40.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.5%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year58.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y301.81%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y438.74%
OCF growth 3Y34.47%
OCF growth 5Y44.76%